Your session is about to expire
← Back to Search
Vestibular Retraining for Vestibular Deficit
N/A
Waitlist Available
Led By Eytan A David, MD
Research Sponsored by Eytan A. David
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, 12 rehabilitation sessions, an average of 7 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the effectiveness of two sets of exercises for people with balance issues. One set uses footplate sensors and visual feedback. The other is traditional exercises done at home.
Who is the study for?
This trial is for individuals with a confirmed unilateral vestibular weakness, causing balance issues and dizziness. They must have had symptoms for over six months and not be affected by other conditions like fluctuating vestibular symptoms, poor vision, diabetes, or cognitive impairments that would hinder participation.
What is being tested?
The study compares two types of rehabilitation: exercises on footplate sensors with visual feedback versus traditional at-home head-shaking exercises. It aims to see which method better improves balance and quality of life in patients with inner ear-related balance disorders.
What are the potential side effects?
While the document does not specify side effects, typical reactions to vestibular retraining can include temporary increased dizziness during adaptation to the exercises.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, 12 rehabilitation sessions, an average of 7 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, 12 rehabilitation sessions, an average of 7 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Dizziness Handicap Inventory
SOT composite score
Secondary study objectives
ABC Score
DHI component scores
FES-I score
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Vestibular retraining with dynamic posturographyExperimental Treatment1 Intervention
12 sessions, twice per week, of rehabilitation exercises last about 20 minutes, using CDP and interactive visual feedback
Group II: At-home rehabilitation exercisesActive Control1 Intervention
Daily rehabilitation exercises involving nodding and shaking of the head
Find a Location
Who is running the clinical trial?
Eytan A. DavidLead Sponsor
1 Previous Clinical Trials
13 Total Patients Enrolled
1 Trials studying Dizziness
13 Patients Enrolled for Dizziness
Eytan A David, MDPrincipal InvestigatorUniversity of British Columbia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have problems with your lower body joints or have had joint replacement surgery.You have a neurological or proprioception (sense of body position) deficit.You have diabetes.You have a confirmed problem with balance in one ear, shown by specific tests or if it's not diagnosed yet.You have conditions that cause your balance or inner ear symptoms to come and go, like Menière's disease or perilymphatic fistula.You are currently experiencing benign paroxysmal positional vertigo (BPPV).You have a dizziness handicap inventory score higher than 30 when you join the study.You are receiving treatment that might make it hard for you to keep your balance or stand up.You have difficulty seeing or cannot see at all.You still feel dizzy after being told that your vertigo (dizziness) from benign paroxysmal positional vertigo has gone away.You have had symptoms for more than six months that have not gone away.
Research Study Groups:
This trial has the following groups:- Group 1: At-home rehabilitation exercises
- Group 2: Vestibular retraining with dynamic posturography
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.